Dr Marie-Claude Gregoire is currently Head of Directorate, Isotopes, Radiobiology, and Environment at Canadian Nuclear Laboratories. Marie moved to Australia in 2005 to establish and lead the in vivo molecular imaging platform at Nuclear Science and Technology Organisation. She established and led the LifeSciences division in ANSTO between 2011 and 2016. Marie-Claude worked in the industry for 2 years, and at Mass General Hospital, Boston, for another two years, before being recruited at the Centre National de la Recherche Scientifique (CNRS). She spent 12 years working as a platform and research leader in molecular imaging with nuclear techniques in partnership with the Commissariat des Energies Alternatives (CEA), France.
Her main research interests are in the functional exploration of biological pathways with complementary nuclear techniques and multi-modality imaging such as in vivo PET, SPECT, CT, MRI, and post-mortem imaging. Marie-Claude has produced over 100 journal publications and conferences.